Try our Advanced Search for more refined results
March 31, 2017
AbbVie Inc. v. Novartis Vaccines and Diagnostics, Inc. et al
Case Number:
3:17-cv-01815
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
August 31, 2017
Unclear Grammar Lands AbbVie-Novartis IP Row In Arbitration
A California federal judge on Thursday sent AbbVie Inc.'s suit seeking to nix Novartis' hepatitis C patents to arbitration, finding that while a licensing agreement between the companies was so grammatically unclear he consulted his Chicago Manual of Style, the ambiguity triggers a presumption in favor of the Federal Arbitration Act.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login